Full Course Description


Advanced ADHD Management: Diagnostic Strategies, Cutting-Edge Prescribing & Personalized Patient Plans

Unlock the tools to transform your ADHD care across all age groups! This comprehensive one-day training will equip you with the latest in diagnostic strategies, cutting-edge pharmacological treatments, and personalized management techniques for patients from childhood through adulthood. You’ll gain practical insights into addressing co-occurring conditions, improving patient outcomes, and streamlining your practice.
Learn from expert Daniel E. Wesemann, DNP, MSW, RN, APRN, PMHNP-BC.  Dr. Weseman shares from his extensive experience in psychiatric and mental health practice, research focused on ADHD identification and treatment and holds the title of president of the International Society of Psychiatric Nurses. 

 

What you can expect to incorporate into practice:

  • ADHD symptoms and DSM-5 diagnostic criteria
  • Unique challenges across childhood, adolescence & adulthood
  • Screen and manage co-occurring conditions like anxiety and depression
  • ADHD diagnosis at different life stages
  • Practical treatment plans: Medication, behavioral therapies & lifestyle
  • Family and caregiver roles at various stages of the lifespan
  • Learn effective academic, workplace, and social strategies for success
  • Longitudinal studies on ADHD outcomes
  • Gain expert insights from real-life case studies 

Elevate your expertise and confidently tackle ADHD at every stage of life—because your patients deserve nothing less!

Program Information

Objectives

  1. Identify the key symptoms and diagnostic criteria of ADHD in children, adolescents, and adults, according to DSM-5 TR guidelines. 
  2. Analyze the impact of ADHD on cognitive, emotional, and social development across different stages of life. 
  3. Evaluate various treatment approaches, including medication, behavioral therapy, and lifestyle interventions, for managing ADHD in different age groups. 
  4. Assess the challenges and co-occurring conditions commonly associated with ADHD, such as anxiety, depression, and learning disabilities, across the lifespan. 
  5. Discuss the role of family, educators, and healthcare professionals in supporting individuals with ADHD from childhood through adulthood. 
  6. Develop strategies for promoting academic, occupational, and social success in individuals with ADHD at different life stages.

Outline

ADHD Symptoms and Diagnostic Criteria

  • ADHD diagnostic criteria (DSM-5 TR)
  • Differences in symptom presentation across age groups
  • Diagnostic challenges and considerations in adults
  • Case studies: ADHD diagnosis at different life stages
ADHD and Development Across the Lifespan
  • ADHD and early childhood development
  • Academic and social challenges during adolescence
  • ADHD’s effect on adult relationships, careers, and daily functioning
  • Longitudinal studies on ADHD outcomes
Treatment Approaches for ADHD
  • Pharmacological treatments (stimulants, nonstimulants)
  • Behavioral and cognitive therapies tailored to different life stages 
  • Integrative and lifestyle interventions (nutrition, exercise, mindfulness)
  • Treatment plans: Case studies for children, adolescents, and adults
Co-Occurring Conditions and ADHD
  • ADHD and its overlap with anxiety, depression, and learning disabilities
  • Screening and managing comorbidities
  • Age-related differences in co-occurrence and treatment strategies
  • Case examples of ADHD management with co-occurring conditions
Support Systems and ADHD Management
  • Family and caregiver roles at different life stages
  • Educational accommodations and individualized education plans (IEPs)
  • Healthcare collaboration and interdisciplinary care
  • Advocacy and community resources for ongoing support
Strategies for Success with ADHD
  • Academic success for kids: Study habits, time management, and executive function support
  • Adult workplace strategies: Time management, task prioritization, and organizational skills
  • Enhancing social skills and relationship-building across life stages
  • Success stories: Overcoming ADHD challenges at different ages

Target Audience

  • Nurse Practitioners
  • Physician Assistants
  • Clinical Nurse Specialists
  • Physicians
  • Nurses

Copyright : 05/22/2025

Psychopharmacology of ADHD

Stephanie Shafer, MSN, ANP-BC, PMHNP-BC, will deliver an advanced and updated review of stimulant (e.g., methylphenidate, amphetamines) and non-stimulant (e.g., atomoxetine, guanfacine) medications, with a particular focus on understanding the mechanisms of action, how they differ, and how one might synergistically compliment another. Learn how these medications affect the brain’s chemistry and function to alleviate ADHD symptoms, allowing for a deeper appreciation of their therapeutic potential. Central to the discussion will be the identification of presenting symptomatology and the evaluating of treatment outcomes. This focus will provide the knowledge and skills needed to adeptly navigate the evolving landscape of ADHD management.

By the talk’s conclusion, you will possess a robust understanding of ADHD’s neurobiological basis, as well as a comprehensive knowledge of the mechanisms by which available medications act. Deliver personalizing care for patients with ADHD to enhance their quality of life and daily functioning to the future.

Program Information

Objectives

  1. Explain the key neurobiological factors involved in ADHD, including neurotransmitter systems, brain regions implicated, and how they contribute to the symptoms of the disorder.
  2. Evaluate the pharmacological treatments available for ADHD, including stimulant medications (e.g., methylphenidate, amphetamines) and non-stimulant mediations (e.g., atomoxetine, guanfacine).
  3. Differentiate ADHD from common differentials and tailor pharmacotherapy to individual patients.
  4. Analyze the effectiveness of ADHD medications, while also considering potential side effects.

Outline

Neurobiology of ADHD

  • Neurotransmitter systems
  • Brain regions implicated
  • Contribution to symptoms
Examine Pharmacological Treatment Options
  • Stimulant medications
    • Methylphenidate
    • Amphetamines
  • Non-stimulant medications
    • Atomoxetine
    • Guanfacine, etc.
  • Mechanisms of action
  • Efficacy and effectiveness
  • Differences and combinations
Individualized Treatment Strategies
  • Differential diagnosis
    • Distinguish ADHD from common differentials
    • Consideration of comorbid psychiatric conditions
  • Tailoring pharmacotherapy
    • Customize treatment plans based on individual patient profiles
    • Adjust dosage and medication type as needed
  • Address overlapping symptomatology
    • Strategies to manage symptoms that overlap with other disorders
    • Coordinate care with other healthcare providers
Evaluate Treatment Outcomes & Side Effects
  • Effectiveness of Medications
    • Reduction of ADHD symptoms
    • Improvement in daily functioning
    • Cognitive and emotional beliefs
  • Side Effects
    • Common side effects of ADHD medications
    • Strategies to minimize side effects

Copyright : 03/21/2024

Adult ADHD Medications & The Recent Increase in Prevalence

There has been a lot of buzz about Attention-Deficit/Hyperactivity Disorder (ADHD) in the media lately. The number of adults seeking ADHD diagnosis and treatment has rapidly increased in the past 3 years and as a result, we now have a shortage of Adderall. However, it remains to be estimated that 80% of adults with ADHD are UNDIAGNOSED.

In this session for the Modern Clinician, you’ll understand:

  • Implicit Bias – are you harboring negative feelings about diagnosing and treating Adult ADHD, or whether Adult ADHD is real?
  • Neurobiology of ADHD – a brief and digestible, yet thorough update on our current understanding of pathophysiology of ADHD
  • Safely treating attention deficit symptoms with stimulants and non-stimulants
  • Medication Management: how to choose, start, taper, and monitor effectiveness

Program Information

Objectives

  1. Analyze the prevalence, pathophysiology, and manifestations of Adult ADHD.
  2. Anticipate the deficits in, and impacts of, Adult ADHD.
  3. Acknowledge any implicit bias and develop a position of compassion and empathy.
  4. Express confidence that you can diagnose and manage Adult ADHD.

Outline

Neuroanatomy and pathophysiology

  • The cortex, limbic system, and brain stem structures and functions
  • Genetics of ADHD and brain structures involved
  • Dopamine pathway
  • Norepinephrine pathway
  • Brain wave patterns – regulating alertness
Executive Function (EF)
  • Disorder of doing what you know
  • Elements of EF
  • Evolution of and innate development of EF
  • Deficits result in Impairments = Executive Dysfunction
  • Executive Dysfunction is situationally dependent
  • heterogeneity of impairments/symptoms
Assessment
  • DSM-V
  • A clinicians’ duty
  • Diagnosis rates, average ages and impacts of late diagnosis
  • Differential diagnosis and Diagnostic process
    • Rating scales
    • Getting input from collaterals
    • tips for differentiating diagnosis
Treatment
  • Guiding principles of treatment
  • Stimulants deep dive
    • Amphetamine
    • Methylphenidate
  • Non-stimulants deep dive
    • Alpha agonists
    • Norepinephrine reuptake inhibitors
    • Off-label medications
  • Benefits are addictive, combinations limited by side effects
    • A handy prescribing reference chart to use in practice
  • Micronutrients
  • Lifestyle and therapeutic interventions
    • Guiding principles and evidence-based recommendations
  • Comorbidities
    • MDD and treatment options
    • GAD and treatment options
    • ASD and treatment options

Target Audience

  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Physicians
  • Physician Assistants

Copyright : 04/21/2023

Pediatric Pharmacology

The diagnosis and management of ADHD in children and youth has been particularly challenging for primary care clinicians. Mental health clinicians are not a solution for many families due to financial barriers, demographic barriers, and scarcity. This results in increased demand and expectation or the primary care providers to diagnose, treat and manage ADHD.  

Program Information

Objectives

  1. Determine the relevant epidemiology of ADD/ADHD.
  2. Formulate a diagnosis ADD/ADHD based off the DSM-5 criteria.
  3. Optimize appropriate nonpharmacological treatment options.
  4. Analyze the pharmacological properties of amphetamine salts dosage forms.
  5. Select appropriate medications based off the most up to date literature and pharmacogenomics.

Outline

ADHD Epidemiology 

  • Prevalence 
  • Risk Factors 

Diagnosis 

  • DSM-5 Criteria 
  • Inattention 
  • Hyperactivity and Impulsivity 

Treatment Recommendations 

  • Behavior Management – Parent 
  • Classroom Interventions 
  • Medications 
  • Treatment Plan 

Medications 

  • Stimulants 
    • First line... methylphenidate and amphetamine 
    • Second line 
  • Medication Trials 
  • Non-Stimulants 
     

Target Audience

  • Nurses
  • Nurse Practitioners
  • Advanced Practice Registered Nurses
  • Physician Assistants
  • Physicians

Copyright : 05/17/2023

Reframing ADHD

Some of the most powerful ways of working with neurodiverse clients are unfortunately the most overlooked. For ADHD therapy to be effective, therapists must look beyond simple skills training or behavioral changes on the part of the client. Identifying meaningful environmental changes in relationships, the workplace, and the classroom provide critical keys to successful outcomes. When applied, they can truly help people struggling with ADHD flourish, affirming the many gifts that often come with neurodiversity. In this session, you’ll discover:

  • Advanced approaches to support clients with ADHD that go beyond simple behavioral changes
  • How to know which environmental, workplace, and classroom accommodations will result in success and well-being for clients
  • How to reduce shame and enhance self-worth with ADHD clients from a place of full appreciation and affirmation of their unique skills and abilities

Program Information

Objectives

  1. Distinguish pathologizing from neutral language for discussing and documenting ADHD features.
  2. Develop both individual and environmental supports for individuals with ADD/ADHD.
  3. Integrate an appreciation and affirmation of neurodivergence in your work with the ADD/ADHD client.
  4. Theorize on the value of the term “neurodiversity” and “neurodivergence” in clinical practice.

Outline

  • Using caution with clinical and diagnostic language around ADHD
  • How we talk about ADHD – a gift or a disorder?
  • Collaborating rather than teaching
  • Clarifying client-focused treatment goals around behavior change
  • Over-looked ways to support an ADHD client that don’t involve behavior change
  • Exploring our clients’ lived experience of brain differences
  • Support and interventions for task avoidance, procrastination, and distractibility

Target Audience

  • Counselors
  • Social Workers
  • Psychologists
  • Marriage & Family Therapists
  • Addiction Counselors
  • Physicians
  • Physician Assistants
  • Nurses
  • Nurse Practitioners 
  • Other Mental Health Professionals

Copyright : 03/17/2023

ADHD 2.0

For all the gains we've made in understanding and treating ADHD, we still get one core component wrong: focusing on deficits rather than strengths.

In ADHD 2.0, world-renowned author Edward M. Hallowell, MD, draws on the latest science to provide an arsenal of new strategies and lifestyle hacks to help your clients thrive with ADHD, including how to:

  • Look at ADHD as a spectrum of traits
  • Enhance the creativity and entrepreneurial spirit inherent in the ADHD mind
  • Embrace the innate neurological tendencies as an antidote to negative thinking

As inspiring as it is practical, you will leave with the confidence to help your ADHD clients tap into the power of this mercurial condition and find the key that unlocks their potential!

Program Information

Objectives

  1. Apply a non-medication technique based on an understanding of connectomes and neural networks on how to limit the excessive brooding and ruminating that so plagues people with ADHD.
  2. Propose strength-based strategies to counter deficit-focused approaches associated with ADHD.

Outline

  • ADHD: A Spectrum of Traits 
  • The Healing Power of Connection 
  • Understanding the Demon of the Mind 

Target Audience

  • Addiction Professionals 
  • Licensed Clinical/Mental Health Counselors 
  • Marriage & Family Therapists 
  • Nurses 
  • Occupational Therapists 
  • Occupational Therapy Assistants 
  • Psychologists 
  • School Administrators 
  • Social Workers 
  • Speech-Language Pathologists 
  • Teachers/School-Based Personnel 

Copyright : 10/10/2022

ADHD in Women: Hormonal Influences Across the Lifespan

Join Dr. Jane Indergaard, expert in ADHD and women (with a focus on hormones) where she’ll equip you with actionable strategies to improve care for women and girls with ADHD and stay ahead in the evolving research and treatment landscape. 

Program Information

Objectives

  1. Identify the implications of divergent patterns of ADHD in girls and women on treatment.
  2. Determine the impact of hormonal influences on ADHD symptom expression.
  3. Choose strategies for improved management of symptoms for women with ADHD in menopause.

Outline

ADHD in Girls & Women: The Problem 

  • Sex Disparity in ADHD – Overview of facts contributing to referral and diagnostic bias 
  • Symptom Presentation in Girls & Women – Differences in symptom expression leading to missed diagnoses 
  • Hiding in Plain Sight – Masking in females, its emotional toll, and impact on delayed diagnosis 
  • Comorbidity in Females – Common comorbidities contributing to ADHD misdiagnosis and underdiagnosis 
  • Consequences of Delayed Diagnosis – A preventable public health issue 

 

Etiology of Divergent ADHD Patterns in females:  Possible Mechanisms Involved 

  • Gonadal Hormone Effects on Brain Development – Gender differences in fetal brain development and their role in ADHD onset and symptom variation 
  • Hormonal Influence on Brain and Behavior – Estrogen’s impact on brain function and attentional systems and its relevance to ADHD 

 

Hormone Fluctuations and ADHD: Research & Clinical Findings 

  • Prepuberty: Early puberty's link to riskier ADHD behaviors 
  • Adolescence/Young Adulthood: Menstrual cycle impact on ADHD symptoms; management strategies 
  • Pregnancy/Peripartum: Obstetric risks, stimulant safety, and treatment recommendations 
  • Postpartum: Executive function challenges, hormonal shifts, and mood disorder risks in ADHD 
  • Menopause: Hormonal drops worsening ADHD symptoms; management approaches. 
  • Old Age: ADHD in older adults, screening, and diagnosis considerations 
  • Evidence Limitations – Limited research, case studies, emerging evidence for life stages 

 

Emerging Research on Estrogen’s Role in ADHD:  

Part of a Larger System 

 

Pharmacotherapy and Gender:  

Medication efficacy for women from a recent systematic review 

 

Recommendations for Improved Clinical Practice and Future Research 

Target Audience

  • Medical Providers 
  • Nurses/ Nurse Practitioners 
  • Licensed Clinical/Mental Health Counselors 
  • Psychologists 
  • Social Workers 
  • Marriage & Family Therapists 
  • Occupational Therapists 
  • Teachers/School-Based Personnel 
  • Speech-language Pathologists

Copyright : 12/12/2024